Harvard Bioscience Sees Q4 Sales $23.700M-$25.500M vs $24.500M Est
Benzinga Newsdesk 9 hours ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $23.700 million-$25.500 million vs $24.500 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $23.700 million-$25.500 million vs $24.500 million analyst estimate.